HomeCompareAERI vs VICI

AERI vs VICI: Dividend Comparison 2026

AERI yields 13.11% · VICI yields 6.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VICI wins by $918.8K in total portfolio value· pulled ahead in Year 4
10 years
AERI
AERI
● Live price
13.11%
Share price
$15.25
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.4K
Annual income
$2,963.65
Full AERI calculator →
VICI
VICI Properties Inc.
● Live price
6.52%
Share price
$27.32
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$966.2K
Annual income
$607,376.13
Full VICI calculator →

Portfolio growth — AERI vs VICI

📍 VICI pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAERIVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AERI + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AERI pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AERI
Annual income on $10K today (after 15% tax)
$1,114.75/yr
After 10yr DRIP, annual income (after tax)
$2,519.10/yr
VICI
Annual income on $10K today (after 15% tax)
$554.58/yr
After 10yr DRIP, annual income (after tax)
$516,269.71/yr
At 15% tax rate, VICI beats the other by $513,750.61/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AERI + VICI for your $10,000?

AERI: 50%VICI: 50%
100% VICI50/50100% AERI
Portfolio after 10yr
$506.8K
Annual income
$305,169.89/yr
Blended yield
60.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

AERI
Analyst Ratings
15
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$15.25
0.0% upside vs current
Range: $15.25 — $15.25
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+15.7% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AERI buys
0
VICI buys
0
No recent congressional trades found for AERI or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAERIVICI
Forward yield13.11%6.52%
Annual dividend / share$2.00$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3%
Portfolio after 10y$47.4K$966.2K
Annual income after 10y$2,963.65$607,376.13
Total dividends collected$21.1K$926.2K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$15.25$31.60

Year-by-year: AERI vs VICI ($10,000, DRIP)

YearAERI PortfolioAERI Income/yrVICI PortfolioVICI Income/yrGap
1$12,011$1,311.48$11,361$941.49+$650.00AERI
2$14,324$1,472.22$13,320$1,481.32+$1.0KAERI
3$16,968$1,640.86$16,284$2,405.01+$684.00AERI
4← crossover$19,972$1,816.53$21,040$4,071.78$1.1KVICI
5$23,369$1,998.27$29,209$7,285.49$5.8KVICI
6$27,190$2,185.12$44,443$14,006.51$17.3KVICI
7$31,469$2,376.08$75,822$29,512.55$44.4KVICI
8$36,242$2,570.14$148,733$69,726.75$112.5KVICI
9$41,545$2,766.31$344,394$189,413.75$302.8KVICI
10$47,417$2,963.65$966,234$607,376.13$918.8KVICI

AERI vs VICI: Complete Analysis 2026

AERIStock

Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension; and Rocklatan, a once-daily fixed-dose combination of Rhopressa and latanopros to reduce IOP to treat patients with open-angle glaucoma or ocular hypertension. The company also develops AR-15512 to treat signs and symptoms of dry eye; and AR-1105 and AR-14034 SR sustained-release implants focused on retinal diseases. It has a collaborative research, development, and licensing agreement with DSM Biomedical. Aerie Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Durham, North Carolina.

Full AERI Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this AERI vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AERI vs SCHDAERI vs JEPIAERI vs OAERI vs KOAERI vs MAINAERI vs NNNAERI vs EPRTAERI vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.